Paper40970331
Next-generation antimicrobials: A review of phage lysins as precision weapons against drug-resistant pathogens.
Cui X and 6 others. Virulence, 2025. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Next-generation antimicrobials: A review of phage lysins as precision weapons against drug-resistant pathogens. Papers, record 40970331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40970331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Next-generation antimicrobials: A review of phage lysins as precision weapons against drug-resistant pathogens.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Development | Major topic |
| Bacteriophages | Major topic |
| Drug Resistance, Microbial | Major topic |
| Anti-Infective Agents | Major topic |
| Hydrolases | Major topic |
| Humans | |
| Animals | |
| Chimerin Proteins | |
| Cell Membrane Permeability | |
| Clinical Trials as Topic |
Source PubMed
References158
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,433,070 | Sensitive and rapid detection of staphylococcus aureus in milk via cell binding domain of lysin. | Biosens Bioelectron | 2016 | https://conductscience.org/library/papers/26433070 | PubMed |
| 3 | 21,048,011 | LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. | J Clin Microbiol | 2011 | https://conductscience.org/library/papers/21048011 | PubMed |
| 4 | 29,882,827 | Structure of an Acinetobacter Broad-Range Prophage Endolysin Reveals a C-Terminal α-Helix with the Proposed Role in Activity against Live Bacterial Cells. | Viruses | 2018 | https://conductscience.org/library/papers/29882827 | PubMed |
| 5 | 35,308,352 | Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic Resistance. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35308352 | PubMed |
| 6 | 19,348,786 | The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19348786 | PubMed |
| 7 | 29,203,497 | Outer Membrane Vesicles (OMV)-based and Proteomics-driven Antigen Selection Identifies Novel Factors Contributing to Bordetella pertussis Adhesion to Epithelial Cells. | Mol Cell Proteomics | 2018 | https://conductscience.org/library/papers/29203497 | PubMed |
| 8 | 30,880,427 | Impacts of food matrix on bacteriophage and endolysin antimicrobial efficacy and performance. | Crit Rev Food Sci Nutr | 2020 | https://conductscience.org/library/papers/30880427 | PubMed |
| 9 | 38,773,507 | Outer membrane vesicles generated by an exogenous bacteriophage lysin and protection against Acinetobacter baumannii infection. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/38773507 | PubMed |
| 10 | 32,985,336 | Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection. | Gut Microbes | 2020 | https://conductscience.org/library/papers/32985336 | PubMed |
| 11 | 30,642,930 | ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30642930 | PubMed |
| 12 | 37,608,144 | A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa. | Eur J Clin Microbiol Infect Dis | 2023 | https://conductscience.org/library/papers/37608144 | PubMed |
| 13 | 31,387,285 | Application of the Phage Lysin Ply5218 in the Treatment of Streptococcus suis Infection in Piglets. | Viruses | 2019 | https://conductscience.org/library/papers/31387285 | PubMed |
| 14 | 38,899,839 | Discovery of Antimicrobial Lysins from the "Dark Matter" of Uncharacterized Phages Using Artificial Intelligence. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38899839 | PubMed |
| 15 | 37,561,151 | Rapid bacteriolysis of Staphylococcus aureus by lysin exebacase. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37561151 | PubMed |
| 16 | 29,776,929 | Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci. | Appl Environ Microbiol | 2018 | https://conductscience.org/library/papers/29776929 | PubMed |
| 17 | 26,862,197 | From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria. | Biochem Soc Trans | 2016 | https://conductscience.org/library/papers/26862197 | PubMed |
| 18 | 25,744,664 | High-yield production of a functional bacteriophage lysin with antipneumococcal activity using a plant virus-based expression system. | J Biotechnol | 2015 | https://conductscience.org/library/papers/25744664 | PubMed |
| 19 | 26,955,368 | Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity. | Front Microbiol | 2016 | https://conductscience.org/library/papers/26955368 | PubMed |
| 20 | 31,185,183 | Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage? | Annu Rev Microbiol | 2019 | https://conductscience.org/library/papers/31185183 | PubMed |
| 21 | 23,043,507 | Diversity in bacterial lysis systems: bacteriophages show the way. | FEMS Microbiol Rev | 2013 | https://conductscience.org/library/papers/23043507 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,699,873 | A chimeric, half-life extended lysin with a unique mode of action. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42699873 | PubMed |
| 42,653,442 | Beyond the Barrier: Overcoming Ocular Antimicrobial Resistance Through AI and Novel Therapeutics. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653442 | PubMed |
| 42,568,827 | EV-LYSG101: Extracellular Vesicles Loaded With Lysin LYSG101 for Potent Anti-Staphylococcal Activity. | J Extracell Biol | 2026 | https://conductscience.org/library/papers/42568827 | PubMed |
| 42,539,602 | Bacteriophage lysins: a promising strategy for combating foodborne pathogens in food safety. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42539602 | PubMed |
| 42,267,833 | Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions. | Clin Microbiol Rev | 2026 | https://conductscience.org/library/papers/42267833 | PubMed |
| 42,051,596 | Translational barriers to phage endolysin deployment for antimicrobial resistance control in Africa. | Front Antibiot | 2026 | https://conductscience.org/library/papers/42051596 | PubMed |
| 41,953,439 | Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41953439 | PubMed |
| 41,784,724 | Role of Disulfide Bond in Modulating the Antibacterial Activity and Structure of Cathelicidin-DM Peptides. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41784724 | PubMed |
| 41,750,501 | Examining the Effects: Lack of Impact by Endolysin and Phage Treatment on Rotifer and Larvae Microbiota. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/41750501 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| LYZ | 4,069 | PubTator's text mining | https://conductscience.org/library/genes/4069 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40970331
GET https://conductscience.org/api/papers/v1/40970331/references?page=2